Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

25.45
+0.70002.83%
Post-market: 25.450.00000.00%16:59 EDT
Volume:296.73K
Turnover:7.49M
Market Cap:699.90M
PE:-9.47
High:25.77
Open:25.17
Low:24.78
Close:24.75
Loading ...

Xilio Therapeutics Reports 2024 Financial Results and Pipeline Progress

TIPRANKS
·
12 Mar

Mineralys Therapeutics 12.96M share Secondary priced at $13.50

TIPRANKS
·
12 Mar

Dianthus Therapeutics: Promising Growth Potential with Innovative DNTH103 and Strong Financial Position

TIPRANKS
·
12 Mar

Argenica Therapeutics Unveils Strategic Plans at Euroz Hartley’s Conference

TIPRANKS
·
12 Mar

Cynata Therapeutics Engages Investors at Euroz Hartleys Conference

TIPRANKS
·
12 Mar

Capstone Therapeutics Announces Follow-On Public Offering

TIPRANKS
·
12 Mar

Astria Therapeutics: Promising Developments and Strategic Advancements Justify Buy Rating

TIPRANKS
·
12 Mar

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
12 Mar

Trevi Therapeutics to Report Fourth Quarter and Year End 2024 Financial Results and Provide a Corporate Update on March 18, 2025

PR Newswire
·
12 Mar

Dianthus Therapeutics Q4 EPS $(0.81) Beats $(0.85) Estimate, Sales $1.32M Beat $859.70K Estimate

Benzinga
·
12 Mar

Press Release: Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results

Dow Jones
·
12 Mar

Knight Therapeutics Up Over 12%, on Pace for Largest Percent Increase Since October 2019 -- Data Talk

Dow Jones
·
12 Mar

Buy Rating for Astria Therapeutics: Promising Clinical Advancements and Strong Financial Position

TIPRANKS
·
11 Mar

Knight Therapeutics upgraded to Buy from Hold at Mackie Research Capital

TIPRANKS
·
11 Mar

Xilio Therapeutics files $250M mixed securities shelf

TIPRANKS
·
11 Mar

Seaport Therapeutics Strengthens Leadership with New Audit Committee Chair

TIPRANKS
·
11 Mar